Global Neurovascular or Interventional Neurology Devices Market – Analysis, Size, Share, Trends and Forecast, 2016 – 2022


Select Your License Type


samplerequest
makeanenquiry
download
Discount




Figure: Global Neurovascular or Interventional Neurology Devices Market Projection


The global market for neurovascular devices was valued at around USD 1.44 billion in 2015 and is expected to reach USD 2.25 billion by 2022, growing at a CAGR of around 7.0% during the forecast period of 2016 to 2022. Neurovascular disease is a leading cause of adult disabilities and death; and includes any abnormality of the blood vessels within or supplying blood to the brain and spine. This includes narrowing of the arteries, which decreases blood flow to the brain and increases the risk of a stroke. Additionally, a neurovascular disease may cause a weakening of the arteries that can lead to brain aneurysms and other conditions that increase the risk of a stroke. According to the World Health Organization, an estimated 15 million people worldwide suffer a stroke each year. In the U.S., around 800,000 people have a stroke annually. Of these, 87% have an acute ischemic stroke (AIS), and 13% have a hemorrhagic stroke. Neurovascular devices are used by neurosurgeons and neuro-interventionalists to treat stroke.

Rise in base of geriatric population, increasing incidence rates of diabetes worldwide, large base of patient pool with neurovascular diseases, changing lifestyle habits of the people and growing healthcare awareness among the population are some of the driving factors of this market. In addition, improving healthcare infrastructure across the globe, growing demand for minimally invasive and non-invasive surgical procedures are further expected to propel the market in the coming years. Moreover, innovative technologies coupled with rise in acceptance of novel technologies in the emerging markets further increase the adoption of neurovascular devices.

Geographically, North America is the leading contributor to the market and is expected to retain its position during the forecast period due to the presence of large number of geriatric population, increasing adoption of neurovascular devices by neurosurgeons and large base of patients with neurovascular disease. However, Asia-Pacific market is expected to grow at a faster rate during the forecast period. This is predominantly due to increased healthcare awareness, improved economic growth, technological advancements, increasing number of obesity cases and growing awareness among the population.

Companies profiled:

  • Stryker Corporation
  • Medtronic PLC
  • Johnson & Johnson
  • Terumo Corporation
  • Penumbra, Inc.
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Merit Medical Systems, Inc.
  • Microport Scientific Corporation

Report Highlights:

The report delivers a strategic analysis of the global market for neurovascular devices and growth forecast for the period from 2016 – 2022. The scope of the report includes competitive analysis of various market players who are operating in the market, segmental analysis based on type of device. It also covers geographical analysis of the market with growth forecast for the period of 2016e – 2022f. The Porter’s Five Forces analysis and value chain analysis included in the report provides an insight into market dynamics and industry competition.

Moreover, the report also includes growth strategies and entry barriers to be considered to cater to the exact business opportunities in this market. Additionally, to aid in strategic decision making, the report also includes competitive profiling of leading players, recent developments in the industry and various business strategies adopted by them. This report will help players in global neurovascular device market to plan and implement their strategies in different market areas such as emerging geographies, and new technologies

 

1 Scope of the report

1.1 Report description
1.2 Research methodology
1.3 List of abbreviations
1.4 Market segmentation

2 Executive summary
3 Qualitative analysis

3.1 Market overview

3.1.1 Drivers
3.1.2 Restraints

3.2 Porters five forces analysis
3.3 Market share analysis of key players, 2015
3.4 Competitive matrix of the key companies

4 Global neurovascular device market, by type, 2015 – 2022

4.1 Cerebral Thrombectomy Devices
4.2 Carotid Artery Stenting (CAS) System
4.3 Cerebral aneurysm and AVM endovascular embolization systems
4.4 Intracranial Stent Systems
4.5 Flow Diverter for aneurysm

5 Global neurovascular device market, by application, 2015 – 2022

5.1 Stroke
5.2 Cerebral Artery Stenosis
5.3 Cerebral Aneurysm
5.4 Others

6 Global neurovascular device market, by geography, 2015 – 2022

6.1 North America

6.1.1 Cerebral Thrombectomy Devices
6.1.2 Carotid Artery Stenting (CAS) System
6.1.3 Cerebral aneurysm and AVM endovascular embolization systems
6.1.4 Intracranial Stent Systems
6.1.5 Flow Diverter for aneurysm

6.2 Europe

6.2.1 Cerebral Thrombectomy Devices
6.2.2 Carotid Artery Stenting (CAS) System
6.2.3 Cerebral aneurysm and AVM endovascular embolization systems
6.2.4 Intracranial Stent Systems
6.2.5 Flow Diverter for aneurysm

6.3 APAC

6.3.1 Cerebral Thrombectomy Devices
6.3.2 Carotid Artery Stenting (CAS) System
6.3.3 Cerebral aneurysm and AVM endovascular embolization systems
6.3.4 Intracranial Stent Systems
6.3.5 Flow Diverter for aneurysm

6.4 Rest of the World

6.4.1 Cerebral Thrombectomy Devices
6.4.2 Carotid Artery Stenting (CAS) System
6.4.3 Cerebral aneurysm and AVM endovascular embolization systems
6.4.4 Intracranial Stent Systems
6.4.5 Flow Diverter for aneurysm

7 Company profiles

7.1 Stryker Corporation
7.2 Medtronic PLC
7.3 Johnson & Johnson
7.4 Terumo Corporation
7.5 Penumbra, Inc.,
7.6 Boston Scientific Corporation
7.7 Abbott Laboratories
7.8 Merit Medical Systems, Inc.
7.9 Microport Scientific Corporation


Got a Question?

If you have a question to ask our analyst, just fill this form and send it across, our representative will get in touch with you shortly.